Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19

Autor: de Michelena, Paula, Torres, Ignacio, Albert, Eliseo, Bracho, Alma, González-Candelas, Fernando, Navarro, David

Publikováno v: In Journal of Infection April 2022 84(4):579-613

Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients

Autor: Torres, Ignacio, Huntley, Dixie, Tormo, Mar, Calabuig, Marisa, Hernández-Boluda, Juan Carlos, Terol, Maria José, Carretero, Carlos, de Michelena, Paula, Pérez, Ariadna, Piñana, José Luis, Colomina, Javier, Solano Vercet, Carlos, Navarro, David

Publikováno v: Torres, Ignacio Huntley, Dixie Tormo, Mar Calabuig, Marisa Hernández-Boluda, Juan Carlos Terol, Maria José Carretero, Carlos de Michelena, Paula Pérez, Ariadna Piñana, Jose Luis Colomina, Javier Solano Vercet, Carlos Navarro, David 2022 Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients BMC Infectious Diseases 22 1
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instname

Background To investigate the multi-drug resistant bacteria (MDRB) colonization rate in hematological patients hospitalized for any cause using a multi-body-site surveillance approach, and determine the extent to which this screening strategy helped

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2427fd17cfcebb8ea6a007aa5bf8c1
https://hdl.handle.net/10550/82071

Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients.

Autor: Torres I; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Huntley D; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Tormo M; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Calabuig M; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Hernández-Boluda JC; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Terol MJ; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Carretero C; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., de Michelena P; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Pérez A; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Piñana JL; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Colomina J; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain., Solano C; Hematology Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain., Navarro D; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. david.navarro@uv.es.; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain. david.navarro@uv.es.; Department of Microbiology, School of Medicine, University of Valencia, Av. Blasco Ibáñez 17, 46010, Valencia, Spain. david.navarro@uv.es.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2022 Feb 21; Vol. 22 (1), pp. 172. Date of Electronic Publication: 2022 Feb 21.